REVIVA PHARMACEUTICALS HOLDINGS, INC.

Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.

RVPH | US

Overview

Corporate Details

ISIN(s):: VGG8708A1167 (+1 more)
LEI:
Country:: United States of America
Address:: 10080 N WOLFE ROAD, 95014 CUPERTINO
Website:: https://revivapharma.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics for diseases with significant unmet medical needs. The company utilizes a chemical genomics-driven technology platform to develop treatments with improved safety and efficacy profiles. Its primary areas of focus include central nervous system (CNS), respiratory, and metabolic diseases. The company's lead drug candidate, brilaroxazine (RP5063), is in clinical development for multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, and psychosis associated with Alzheimer's and Parkinson's diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REVIVA PHARMACEUTICALS HOLDINGS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REVIVA PHARMACEUTICALS HOLDINGS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for REVIVA PHARMACEUTICALS HOLDINGS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
GH Research PLC Clinical-stage biopharma developing mebufotenin therapies for psychiatric disorders.	United States of America	GHRS
GI Innovation Inc. Develops fusion protein biologics for oncology, allergic, and metabolic diseases.	South Korea	358570
GILEAD SCIENCES, INC. Develops innovative medicines for life-threatening diseases in virology, oncology & inflammation.	United States of America	GILD
GlaxoSmithKline PLC A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.	United Kingdom	GSK
GL Pharm Tech Corp. Develops improved drugs and generics, and licenses proprietary drug formulation technologies.	South Korea	204840
GNI Group Ltd. Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.	Japan	2160
Goodwill Pharma Plc Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.	Hungary	GWPH
Gossamer Bio, Inc. Clinical-stage biopharma developing inhaled therapies for rare pulmonary hypertension.	United States of America	GOSS
Grace Therapeutics, Inc. Develops improved drugs for rare neurological diseases using novel drug delivery technologies.	United States of America	GRCE
Green Cross Holdings A biotech firm in biopharma, diagnostics, digital health, and consumer wellness products.	South Korea	005250